A brief review and clinical application of heart rate variability biofeedback in sports, exercise, and rehabilitation medicine

Physician and Sportsmedicine

Volumn 42, Issue 2, 2014, Pages 88-99

  Prinsloo, Gabriell E ^a,b   Laurie Rauch, H G ^a   Derman, Wayne E ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b International Olympic Committee   (South Africa)

Author keywords

Biofeedback; Heart rate variability; Noncommunicable disease; Psychosocial stress

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; CHRONIC RESPIRATORY TRACT DISEASE; EXERCISE; FEEDBACK SYSTEM; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HEART REHABILITATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; MENTAL STRESS; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NON COMMUNICABLE DISEASE; REHABILITATION MEDICINE; RESPIRATORY SINUS ARRHYTHMIA; RR INTERVAL; SPORT; SYSTEMATIC REVIEW; VAGUS TONE; CHRONIC DISEASE; HEART RATE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOPHYSIOLOGY; REHABILITATION; REVIEW; SPORTS MEDICINE;

BIOFEEDBACK, PSYCHOLOGY; CHRONIC DISEASE; EXERCISE; HEART RATE; HUMANS; REHABILITATION; SPORTS MEDICINE; STRESS, PSYCHOLOGICAL;

EID: 84908333186     PISSN: 00913847     EISSN: 23263660     Source Type: Journal    
DOI: 10.3810/psm.2014.05.2061     Document Type: Article

References (165)

1. World Health Organization. Global Status Report on Noncommunicable Diseases 2010. G eneva: WHO; 2011.
2. Derman WE. Sport physicians should practice the full gamut of their profession: moving from sports medicine to sports and exercise medicine. Curr Sports Med Rep. 2011;10(6):316–317.
3. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007;370(9592):1089–1100.
4. Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol. 2008;51(13):1237–1246.
5. Neylon A, Canniffe C, Anand S, et al. A global perspective on psychosocial risk factors for cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):574–581.
6. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332(7540):521–525.
7. Pyykkonen AJ, Raikkonen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Stressful life events and the metabolic syndrome: the prevalence, prediction and prevention of diabetes (PPP)-Botnia Study. Diabetes Care. 2010;33(2):378–384.
8. Tamashiro KL. Metabolic syndrome: links to social stress and socioeconomic status. Ann N Y Acad Sci. 2011;1231:46–55.
9. Edwards EM, Stuver SO, Heeren TC, Fredman L. Job strain and incident metabolic syndrome over 5 years of follow-up: the coronary artery risk development in young adults study. J Occup Environ Med 2012;54(12):1447–1452.
10. L ehrer P, Feldman J, Giardino N, Song HS, Schmaling K. Psychological aspects of asthma. J Consult Clin Psychol. 2002;70(3):691–711.
11. Rod NH, Kristensen TS, Lange P, Prescott E, Diderichsen F. Perceived stress and risk of adult-onset asthma and other atopic disorders: A longitudinal cohort study. Allergy. 2012;67(11):1408–1414.
12. Vig RS, Forsythe P, Vliagoftis H. The role of stress in asthma: insight from studies on the effect of acute and chronic stressors in models of airway inflammation. Ann N Y Acad Sci. 2006;1088:65–77.
13. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17(3):354–381.
14. Miu AC, Heilman RM, Miclea M. Reduced heart rate variability and vagal tone in anxiety: trait versus state, and the effects of autogenic training. Auton Neurosci-Basic. 2009;145(1–2):99–103.
15. Uusitalo A, Mets T, Martinmaki K, Mauno S, Kinnunen U, Rusko H. Heart rate variability related to effort at work. Appl Ergon. 2011;42(6):830–838.
16. Chandola T, Britton A, Brunner E, et al. Work stress and coronary heart disease: What are the mechanisms? Eur Heart J. 2008;29(5):640–648.
17. Berntson GG, Lozano DL, Chen YJ. Filter properties of root mean square successive difference (RMSSD) for heart rate. Psychophysiology. 2005;42(2):246–252.
18. Berntson GG, Bigger JT Jr, Eckberg DL, et al. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology. 1997;34(6):623–648.
19. Penttila J, Helminen A, Jartti T, et al. Time domain, geometrical and frequency domain analysis of cardiac vagal outflow: Effects of various respiratory patterns. Clin Physiol. 2001;21(3):365–376.
20. Shusterman V, Anderson KP, Barnea O. Spontaneous skin temperature oscillations in normal human subjects. Am J Physiol. 1997;273(3 Pt 2): R1173–R1181.
21. Vaschillo E, Lehrer P, Rishe N, Konstantinov M. Heart rate variability biofeedback as a method for assessing baroreflex function: A preliminary study of resonance in the cardiovascular system. Appl Psychophysiol Biofeedback. 2002;27(1):1–27.
22. Taylor JA, Carr DL, Myers CW, Eckberg DL. Mechanisms underlying very-low-frequency RR-interval oscillations in humans. Circulation. 1998;98(6):547–555.
23. Xhyheri B, Manfrini O, Mazzolini M, Pizzi C, Bugiardini R. Heart rate variability today. Prog Cardiovasc Dis. 2012;55(3): 321–331.
24. Voss A, Schulz S, Schroeder R, Baumert M, Caminal P. Methods derived from nonlinear dynamics for analysing heart rate variability. Philos T R Soc A. 2009;367(1887):277–296.
25. Wu GQ, Arzeno NM, Shen LL, et al. Chaotic signatures of heart rate variability and its power spectrum in health, aging and heart failure. PLoS One. 2009;4(2):e4323.
26. Chen Z, Brown EN, Barbieri R. Characterizing nonlinear heartbeat dynamics within a point process framework. IEEE T Bio-Med Eng. 2010;57(6):1335–1347.
27. Poon CS, Merrill CK. Decrease of cardiac chaos in congestive heart failure. Nature. 1997;389(6650):492–495.
28. Braun C, Kowallik P, Freking A, Hadeler D, Kniffki KD, Meesmann M. Demonstration of nonlinear components in heart rate variability of healthy persons. Am J Physiol. 1998;275(5 Pt 2): H1577–H1584.
29. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvas Electro. 2005;10(1):88–101.
30. Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol. 2008;51(18):1725–1733.
31. Routledge FS, Campbell TS, McFetridge-Durdle JA, Bacon SL. Improvements in heart rate variability with exercise therapy. Can J Cardiol. 2010;26(6):303–312.
32. Bernardi L, Leuzzi S, Radaelli A, Johnston JA, Sleight P. Lowfrequency spontaneous fluctuations of R-R interval and blood pressure in conscious humans: A baroreceptor or central phenomenon? Clin Sci (Lond). 1994;87(6):649–654.
33. Sleight P, La Rovere MT, Mortara A, et al. Physiology and pathophysiology of heart rate and blood pressure variability in humans: Is power spectral analysis largely an index of baroreflex gain? Clin Sci (Lond). 1995;88(1):103–109.
34. Felder RB, Mifflin SW. Baroreceptor and chemoreceptor afferent processing in the solitary tract nucleus. In: Barraco IRA, ed. Nucleus of the Solitary Tract. CRC Press; 1994:169–185.
35. Eckberg DL, Nerhed C, Wallin BG. Respiratory modulation of muscle sympathetic and vagal cardiac outflow in man. J Physiol 1985;365:181–196.
36. Kirchheim HR. Systemic arterial baroreceptor reflexes. Physiol Rev. 1976;56(1):100–177.
37. deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: A beat-to-beat model. Am J Physiol. 1987;253(3 Pt 2):H680–H689.
38. Saul JP, Rea RF, Eckberg DL, Berger RD, Cohen RJ. Heart rate and muscle sympathetic nerve variability during reflex changes of autonomic activity. Am J Physiol. 1990;258(3 Pt 2):H713–H721.
39. Julien C. The enigma of Mayer waves: Facts and models. Cardiovasc Res. 2006;70(1):12–21.
40. Moak JP, Goldstein DS, Eldadah BA, et al. Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Cleve Clin J Med. 2009;76(Suppl 2):S51–S59.
41. Cohen MA, Taylor JA. Short-term cardiovascular oscillations in man: measuring and modelling the physiologies. J Physiol. 2002;542(Pt 3): 669–683.
42. Grasso R, Schena F, Gulli G, Cevese A. Does low-frequency variability of heart period reflect a specific parasympathetic mechanism? J Auton Nerv Syst. 1997;63(1–2):30–38.
43. Houle MS, Billman GE. Low-frequency component of the heart rate variability spectrum: A poor marker of sympathetic activity. Am J Physiol. 1999;276(1 Pt 2):H215–H223.
44. V aschillo E, Vaschillo B, Lehrer P. Heartbeat synchronizes with respiratory rhythm only under specific circumstances. Chest. 2004;126(4):1385–1386; Author reply 1386–1387.
45. Taha BH, Simon PM, Dempsey JA, Skatrud JB, Iber C. Respiratory sinus arrhythmia in humans: An obligatory role for vagal feedback from the lungs. J Appl Physiol. 1995;78(2):638–645.
46. Slovut DP, Wenstrom JC, Moeckel RB, Wilson RF, Osborn JW, Abrams JH. Respiratory sinus dysrhythmia persists in transplanted human hearts following autonomic blockade. Clin Exp Pharmacol Physiol. 1998;25(5):322–330.
47. Guzzetti S, Cogliati C, Turiel M, Crema C, Lombardi F, Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J. 1995;16(8):1100–1107.
48. Innes JA, De Cort SC, Kox W, Guz A. Within-breath modulation of left ventricular function during normal breathing and positive-pressure ventilation in man. J Physiol. 1993;460:487–502.
49. Toska K, Eriksen M. Respiration-synchronous fluctuations in stroke volume, heart rate and arterial pressure in humans. J Physiol. 1993;472:501–512.
50. Triedman JK, Saul JP. Blood pressure modulation by central venous pressure and respiration. Buffering effects of the heart rate reflexes. Circulation. 1994;89(1):169–179.
51. van Ravenswaaij-Arts CM, Kollee LA, Hopman JC, Stoelinga GB, van Geijn HP. Heart rate variability. Ann Intern Med. 1993; 118(6):436–447.
52. Fouad FM, Tarazi RC, Ferrario CM, Fighaly S, Alicandri C. Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol. 1984;246(6 Pt 2):H838–H842.
53. Martinmaki K, Rusko H, Kooistra L, Kettunen J, Saalasti S. Intraindividual validation of heart rate variability indexes to measure vagal effects on hearts. Am J Physiol Heart Circ Physiol. 2006;290(2):H640–H647.
54. Pagani M, Montano N, Porta A, et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation. 1997;95(6):1441–1448.
55. Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ. Transfer function analysis of the circulation: unique insights into cardiovascular regulation. Am J Physiol. 1991;261(4 Pt 2):H1231–H1245.
56. Taylor JA, Myers CW, Halliwill JR, Seidel H, Eckberg DL. Sympathetic restraint of respiratory sinus arrhythmia: implications for vagal-cardiac tone assessment in humans. Am J Physiol Heart Circ Physiol. 2001;280(6):H2804–H2814.
57. Pagani M, Lombardi F, Guzzetti S, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59(2):178–193.
58. Medigue C, Girard A, Laude D, Monti A, Wargon M, Elghozi JL. Relationship between pulse interval and respiratory sinus arrhythmia: A time- and frequency-domain analysis of the effects of atropine. Pflugers Arch. 2001;441(5):650–655.
59. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991;84(2):482–492.
60. Malpas SC. Neural influences on cardiovascular variability: possibilities and pitfalls. Am J Physiol Heart Circ Physiol. 2002;282(1):H6–H20.
61. Al-Ani M, Forkins AS, Townend JN, Coote JH. Respiratory sinus arrhythmia and central respiratory drive in humans. Clin Sci (Lond). 1996;90(3):235–241.
62. Friedman BH. An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biol Psychol. 2007;74(2):185–199.
63. Porges SW. The polyvagal perspective. Biol Psychol. 2007;74(2): 116–143.
64. Nunan D, Sandercock GR, Brodie DA. A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing Clin. 2010;33(11):1407–1417.
65. Wheat AL, Larkin KT. Biofeedback of heart rate variability and related physiology: A critical review. Appl Psychophysiol Biofeedback. 2010;35(3):229–242.
66. Pinna GD, Maestri R, Torunski A, et al. Heart rate variability measures: A fresh look at reliability. Clin Sci (Lond). 2007;113(3):131–140.
67. Achten J, Jeukendrup AE. Heart rate monitoring: Applications and limitations. Sports Med. 2003;33(7):517–538.
68. Agelink MW, Malessa R, Baumann B, et al. Standardized tests of heart rate variability: normal ranges obtained from 309 healthy humans, and effects of age, gender, and heart rate. Clin Auton Res. 2001;11(2):99–108.
69. Cooke WH, Hoag JB, Crossman AA, Kuusela TA, Tahvanainen KU, Eckberg DL. Human responses to upright tilt: A window on central autonomic integration. J Physiol. 1999;517(Pt 2):617–628.
70. Liao D, Barnes RW, Chambless LE, Simpson RJ Jr, Sorlie P, Heiss G. Age, race, and sex differences in autonomic cardiac function measured by spectral analysis of heart rate variability—the ARIC study. Atherosclerosis Risk in Communities. Am J Cardiol. 1995;76(12):906−912.
71. Eckberg DL. The human respiratory gate. J Physiol. 2003;548(Pt 2): 339–352.
72. Sacha J, Pluta W. Alterations of an average heart rate change heart rate variability due to mathematical reasons. Int J Cardiol. 2008;128(3):444–447.
73. Billman GE. The effect of heart rate on the heart rate variability response to autonomic interventions. Front Physiol. 2013;4:222.
74. Sacha J. Why should one normalize heart rate variability with respect to average heart rate. Front Physiol. 2013;4:306.
75. Aubert AE, Seps B, Beckers F. Heart rate variability in athletes. Sports Med. 2003;33(12):889−919.
76. Schroeder EB, Whitsel EA, Evans GW, Prineas RJ, Chambless LE, Heiss G. Repeatability of heart rate variability measures. J Electrocardiol. 2004;37(3):163–172.
77. Maestri R, Raczak G, Danilowicz-Szymanowicz L, et al. Reliability of heart rate variability measurements in patients with a history of myocardial infarction. Clin Sci (Lond). 2010;118(3):195–201.
78. Sandercock GR, Bromley PD, Brodie DA. The reliability of short-term measurements of heart rate variability. Int J Cardiol. 2005;103(3):238–247.
79. Schwartz AR, Gerin W, Davidson KW, et al. Toward a causal model of cardiovascular responses to stress and the development of cardiovascular disease. Psychosom Med. 2003;65(1):22–35.
80. Kivimaki M, Leino-Arjas P, Luukkonen R, Riihimaki H, Vahtera J, Kirjonen J. Work stress and risk of cardiovascular mortality: prospective cohort study of industrial employees. BMJ. 2002;325(7369):857.
81. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005;178(2):339–344.
82. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141(2):122–131.
83. Levy MN. Autonomic interactions in cardiac control. Ann N Y Acad Sci. 1990;601:209–221.
84. Huikuri HV, Ylitalo A, Pikkujamsa SM, et al. Heart rate variability in systemic hypertension. Am J Cardiol. 1996;77(12):1073–1077.
85. Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension. 2003;42(6):1106–1111.
86. L iao D, Cai J, Barnes RW, et al. Association of cardiac autonomic function and the development of hypertension: the ARIC study. Am J Hypertens. 1996;9(12 Pt 1):1147–1156.
87. Dekker JM, Crow RS, Folsom AR, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation. 2000;102(11):1239–1244.
88. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation. 1995;91(7):1936–1943.
89. Kop WJ, Verdino RJ, Gottdiener JS, O’Leary ST, Bairey Merz CN, Krantz DS. Changes in heart rate and heart rate variability before ambulatory ischemic events(1). J Am Coll Cardiol. 2001;38(3):742–749.
90. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC, Schneider WJ. Time course of recovery of heart period variability after myocardial infarction. J Am Coll Cardiol. 1991;18(7):1643–1649.
91. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351(9101):478–484.
92. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59(4):256–262.
93. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 1993;88(3):927–934.
94. Counihan PJ, Fei L, Bashir Y, Farrell TG, Haywood GA, McKenna WJ. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation. 1993;88(4 Pt 1):1682–1690.
95. Fei L, Keeling PJ, Gill JS, et al. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure. Br Heart J. 1994;71(4):322–328.
96. Mortara A, La Rovere MT, Signorini MG, et al. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J. 1994;71(5):422–430.
97. Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997;79(12):1645–1650.
98. Sandercock GR, Brodie DA. The role of heart rate variability in prognosis for different modes of death in chronic heart failure. Pacing Clin Electrophysiol. 2006;29(8):892–904.
99. Huikuri HV, Valkama JO, Airaksinen KE, et al. Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease. Circulation. 1993;87(4):1220–1228.
100. Huang JL, Wen ZC, Lee WL, Chang MS, Chen SA. Changes of autonomic tone before the onset of paroxysmal atrial fibrillation. Int J Cardiol. 1998;66(3):275–283.
101. Fioranelli M, Piccoli M, Mileto GM, et al. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1999;22(5):743–749.
102. Vincenti A, Brambilla R, Fumagalli MG, Merola R, Pedretti S. Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring. Europace. 2006;8(3):204–210.
103. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332(7540):521–525.
104. Brindley DN, Rolland Y. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin Sci (Lond). 1989;77(5):453–461.
105. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord. 1996;20(4):291–302.
106. Min KB, Min JY, Paek D, Cho SI. The impact of the components of metabolic syndrome on heart rate variability: Using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol. 2008;31(5):584–591.
107. Stein PK, Barzilay JI, Domitrovich PP, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabet Med. 2007;24(8):855–863.
108. Soares-Miranda L, Sandercock G, Vale S, et al. Metabolic syndrome, physical activity and cardiac autonomic function. Diabetes Metab Res Rev. 2012;28(4):363–369.
109. Gehi AK, Lampert R, Veledar E, et al. A twin study of metabolic syndrome and autonomic tone. J Cardiovasc Electrophysiol. 2009;20(4):422–428.
110. Singh JP, Larson MG, O’Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000;86(3):309–312.
111. Pfeifer MA, Weinberg CR, Cook DL, et al. Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care. 1984;7(5):447–453.
112. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med. 1993;10(9):820–824.
113. Pagani M, Malfatto G, Pierini S, et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst. 1988;23(2):143–153.
114. Tsai YS, Lai FC, Chen SR, Jeng C. The influence of physical activity level on heart rate variability among asthmatic adults. J Clin Nurs. 2011;20(1–2):111–118.
115. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest. 1994;106(5):1432–1437.
116. Gunduz H, Talay F, Arinc H, et al. Heart rate variability and heart rate turbulence in patients with chronic obstructive pulmonary disease. Cardiol J. 2009;16(6):553–559.
117. Stein PK, Nelson P, Rottman JN, et al. Heart rate variability reflects severity of COPD in PiZ alpha1-antitrypsin deficiency. Chest. 1998;113(2):327–333.
118. Van Gestel AJ, Kohler M, Steier J, Teschler S, Russi EW, Teschler H. Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology. 2011;16(6):939–946.
119. Nolan RP, Kamath MV, Floras JS, et al. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J. 2005;149(6):1137.
120. McCraty R, Atkinson M, Tomasino D. Impact of a workplace stress reduction program on blood pressure and emotional health in hypertensive employees. J Altern Complement Med. 2003;9(3):355–369.
121. Mikosch P, Hadrawa T, Laubreiter K, et al. Effectiveness of respiratorysinus- arrhythmia biofeedback on state-anxiety in patients undergoing coronary angiography. J Adv Nurs. 2010;66(5):1101–1110.
122. Sherlin L, Gevirtz R, Wyckoff S, Muench F. Effects of respiratory sinus arrythmia biofeedback versus passive biofeedback control. Int J Stress Manag. 2009;16:233−248.
123. Moravec CS. Biofeedback therapy in cardiovascular disease: rationale and research overview. Cleve Clin J Med. 2008;75(Suppl 2):S35–S38.
124. Karavidas MK, Lehrer PM, Vaschillo E, et al. Preliminary results of an open label study of heart rate variability biofeedback for the treatment of major depression. Appl Psychophysiol Biofeedback. 2007;32(1):19–30.
125. J oseph CN, Porta C, Casucci G, et al. Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension. 2005;46(4):714–718.
126. Luskin F, Reitz M, Newell K, Quinn T, Haskell W. A controlled pilot study of stress management training of elderly patients with congestive heart failure. Prev Cardiol. 2002;5(4):168–172.
127. Bernardi L, Spadacini G, Bellwon J, Hajric R, Roskamm H, Frey AW. Effect of breathing rate on oxygen saturation and exercise performance in chronic heart failure. Lancet. 1998;351(9112):1308–1311.
128. Swanson KS, Gevirtz RN, Brown M, Spira J, Guarneri E, Stoletniy L. The effect of biofeedback on function in patients with heart failure. Appl Psychophysiol Biofeedback. 2009;34(2):71–91.
129. Del Pozo JM, Gevirtz RN, Scher B, Guarneri E. Biofeedback treatment increases heart rate variability in patients with known coronary artery disease. Am Heart J. 2004;147(3):E11.
130. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992; 85(1 Suppl):I77–I91.
131. Vanoli E, Schwartz PJ. Sympathetic—parasympathetic interaction and sudden death. Basic Res Cardiol. 1990;85(Suppl 1):305–321.
132. Lehrer PM, Vaschillo E, Vaschillo B, et al. Biofeedback treatment for asthma. Chest. 2004;126(2):352–361.
133. Lehrer P, Vaschillo E, Lu SE, et al. Heart rate variability biofeedback: Effects of age on heart rate variability, baroreflex gain, and asthma. Chest. 2006;129(2):278–284.
134. Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback. 2004;29(2):121–133.
135. Hassett AL, Radvanski DC, Vaschillo EG, et al. A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia. Appl Psychophysiol Biofeedback. 2007;32(1):1–10.
136. Lehrer P, Karavidas MK, Lu SE, et al. Voluntarily produced increases in heart rate variability modulate autonomic effects of endotoxin induced systemic inflammation: An exploratory study. Appl Psychophysiol Biofeedback. 2010;35(4):303–315.
137. Ebben MR, Kurbatov V, Pollak CP. Moderating laboratory adaptation with the use of a heart-rate variability biofeedback device (StressEraser). Appl Psychophysiol Biofeedback. 2009;34(4):245–249.
138. Sandercock GR, Brodie DA. The use of heart rate variability measures to assess autonomic control during exercise. Scand J Med Sci Sports. 2006;16(5):302–313.
139. Lewis MJ, Short AL. Exercise and cardiac regulation: what can electrocardiographic time series tell us? Scand J Med Sci Sports. 2010;20(6):794–804.
140. Novak V, Novak P, Kus T, Nadeau R. Slow cardiovascular rhythms in tilt and syncope. J Clin Neurophysiol. 1995;12(1):64–71.
141. Dolezal BA, Chudzynski J, Dickerson D, et al. Exercise training improves heart rate variability after methamphetamine dependency [published online ahead of print October 24, 2013]. Med Sci Sports Exerc. 2013. doi:10.1249/MSS0000000000000201.
142. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation. 2002;106(8):945–949.
143. Malfatto G, Facchini M, Bragato R, Branzi G, Sala L, Leonetti G. Short and long term effects of exercise training on the tonic autonomic modulation of heart rate variability after myocardial infarction. Eur Heart J. 1996;17(4):532–538.
144. Iellamo F, Manzi V, Caminiti G, et al. Dose-response relationship of baroreflex sensitivity and heart rate variability to individuallytailored exercise training in patients with heart failure. Int J Cardiol. 2013;166(2):334–339.
145. Lehrer PM, Vaschillo E, Vaschillo B. Resonant frequency biofeedback training to increase cardiac variability: Rationale and manual for training. Appl Psychophysiol Biofeedback. 2000;25(3):177–191.
146. Vaschillo EG, Vaschillo B, Lehrer PM. Characteristics of resonance in heart rate variability stimulated by biofeedback. Appl Psychophysiol Biofeedback. 2006;31(2):129–142.
147. Landsbergis PA, Dobson M, Koutsouras G, Schnall P. Job strain and ambulatory blood pressure: A meta-analysis and systematic review. Am J Public Health. 2013;103(3):E61–E71.
148. Soufer R. Neurocardiac interaction during stress-induced myocardial ischemia: how does the brain cope? Circulation. 2004;110(13): 1710–1713.
149. Kivimaki M, Nyberg ST, Batty GD, et al. Job strain as a risk factor for coronary heart disease: A collaborative meta-analysis of individual participant data. Lancet. 2012;380(9852):1491–1497.
150. Ferrie JE, Kivimaki M, Shipley MJ, Davey Smith G, Virtanen M. Job insecurity and incident coronary heart disease: the Whitehall II prospective cohort study. Atherosclerosis. 2013;227(1):178–181.
151. Rozanski A, Bairey CN, Krantz DS, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med. 1988;318(16):1005–1012.
152. Krantz DS, Kop WJ, Santiago HT, Gottdiener JS. Mental stress as a trigger of myocardial ischemia and infarction. Cardiol Clin. 1996;14(2):271–287.
153. Goldberg AD, Becker LC, Bonsall R, et al. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation. 1996;94(10):2402–2409.
154. Jiang W, Samad Z, Boyle S, et al. Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am Coll Cardiol. 2013;61(7):714–722.
155. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364(9438):953–962.
156. Arnold SV, Smolderen KG, Buchanan DM, Li Y, Spertus JA. Perceived stress in myocardial infarction: long-term mortality and health status outcomes. J Am Coll Cardiol. 2012;60(18):1756–1763.
157. Akashi YJ, Musha H, Kida K, et al. Reversible ventricular dysfunction takotsubo cardiomyopathy. Eur J Heart Fail. 2005;7(7):1171–1176.
158. Sharma AK, Singh JP, Heist EK. Stress cardiomyopathy: diagnosis, pathophysiology, management, and prognosis. Crit Pathw Cardiol. 2011;10(3):142–147.
159. Cecchi E, Parodi G, Giglioli C, et al. Stress-induced hyperviscosity in the pathophysiology of takotsubo cardiomyopathy. Am J Cardiol. 2013;111(10):1523–1529.
160. Lampert R, Jain D, Burg MM, Batsford WP, McPherson CA. Destabilizing effects of mental stress on ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Circulation. 2000;101(2):158–164.
161. Lane RD, Laukes C, Marcus FI, et al. Psychological stress preceding idiopathic ventricular fibrillation. Psychosom Med. 2005;67(3):359–365.
162. Peacock J, Whang W. Psychological distress and arrhythmia: Risk prediction and potential modifiers. Prog Cardiovasc Dis. 2013;55(6):582–589.
163. Hansson A, Madsen-Hardig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: A study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovasc Disord. 2004;4:13.
164. Wen ZC, Chen SA, Tai CT, Huang JL, Chang MS. Role of autonomic tone in facilitating spontaneious onset of typical atrial flutter. J Am Coll Cardiol. 1998;31(1):602–607.
165. Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996;94(11):2850–2855.